Expression and clinical significance of BIRC6 in human epithelial ovarian cancer

Tumor Biology

Volumn 35, Issue 5, 2014, Pages 4891-4896

  Wang, Lin ^a   Chen, Yan Jie ^a   Hou, Jun ^a   Wang, Ya Yun ^a   Tang, Wen Qing ^a   Shen, Xi Zhong ^a   Tu, Rui Qin ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

BIRC6; EOC; Prognosis; Recurrence

Indexed keywords

BACULOVIRAL IAP REPEAT CONTAINING 6 PROTEIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; BIRC6 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; TISSUE LEVEL; TUMOR DIFFERENTIATION; WESTERN BLOTTING; AGED; CHEMISTRY; MIDDLE AGED; MORTALITY; NEOPLASM; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY; PROGNOSIS;

ADULT; AGED; FEMALE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROGNOSIS;

EID: 84903217501     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1641-6     Document Type: Article

References (22)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA: a cancer journal for clinicians. 2012;62(1):10-29. doi:10.3322/caac.20138.
2. Wright JD, Shah M, Mathew L, Burke WM, Culhane J, Goldman N, et al. Fertility preservation in young women with epithelial ovarian cancer. Cancer. 2009;115(18):4118-26. doi:10.1002/cncr.24461.
3. Anderson GL. Ovarian cancer biomarker screening: still too early to tell. Women's Health (Lond Engl). 2010;6(4):487-90. doi:10.2217/whe.10.33.
4. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57-70. (Pubitemid 30046295)
5. Wong RS. Apoptosis in cancer: from pathogenesis to treatment. Journal of experimental & clinical cancer research : CR. 2011;30:87. doi:10.1186/1756-9966-30-87.
6. Hauser HP, Bardroff M, Pyrowolakis G, Jentsch S. A giant ubiquitin-conjugating enzyme related to IAP apoptosis inhibitors. The Journal of cell biology. 1998;141(6):1415-22. (Pubitemid 28289916)
7. Chen Z, Naito M, Hori S, Mashima T, Yamori T, Tsuruo T. A human IAP-family gene, Apollon, expressed in human brain cancer cells. Biochemical and biophysical research communications. 1999;264(3):847-54. doi:10.1006/bbrc.1999. 1585.
8. Bianchini M, Levy E, Zucchini C, Pinski V, Macagno C, De Sanctis P, et al. Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa. International journal of oncology. 2006;29(1):83-94.
9. Sung KW, Choi J, Hwang YK, Lee SJ, Kim HJ, Lee SH, et al. Overexpression of Apollon, an antiapoptotic protein, is associated with poor prognosis in childhood de novo acute myeloid leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007;13(17):5109-14. doi:10.1158/1078-0432.CCR-07-0693.
10. Lopergolo A, Pennati M, Gandellini P, Orlotti NI, Poma P, Daidone MG, et al. Apollon gene silencing induces apoptosis in breast cancer cells through p53 stabilisation and caspase-3 activation. British journal of cancer. 2009;100(5):739-46. doi:10.1038/sj.bjc.6604927.
11. Van Houdt WJ, Emmink BL, Pham TV, Piersma SR, Verheem A, Vries RG et al. Comparative proteomics of colon cancer stem cells and differentiated tumor cells identifies BIRC6 as a potential therapeutic target. Molecular & cellular proteomics: MCP. 2011;10(12):M111 011353. doi:10.1074/mcp.M111.011353.
12. Ismail EA, Mahmoud HM, Tawfik LM, Habashy DM, Adly AA, El-Sherif NH, et al. BIRC6/Apollon gene expression in childhood acute leukemia: impact on therapeutic response and prognosis. European journal of haematology. 2012;88(2):118-27. doi:10.1111/j.1600-0609.2011.01734.x.
13. Lamers F, Schild L, Koster J, Speleman F, Ora I, Westerhout EM, et al. Identification of BIRC6 as a novel intervention target for neuroblastoma therapy. BMC cancer. 2012;12:285. doi:10.1186/1471-2407-12-285.
14. Low CG, Luk IS, Lin D, Fazli L, Yang K, Xu Y, et al. BIRC6 protein, an inhibitor of apoptosis: role in survival of human prostate cancer cells. PloS one. 2013;8(2):e55837. doi:10.1371/journal.pone.0055837.
15. Ren J, Shi M, Liu R, Yang QH, Johnson T, Skarnes WC, et al. The Birc6 (Bruce) gene regulates p53 and the mitochondrial pathway of apoptosis and is essential for mouse embryonic development. Proc Natl Acad Sci U S A. 2005;102(3):565-70. doi:10.1073/pnas.0408744102. (Pubitemid 40282705)
16. Qiu XB, Goldberg AL. The membrane-associated inhibitor of apoptosis protein, BRUCE/Apollon, antagonizes both the precursor and mature forms of Smac and caspase-9. The Journal of biological chemistry. 2005;280(1):174-82. doi:10.1074/jbc.M411430200. (Pubitemid 40164978)
17. Qiu XB, Markant SL, Yuan J, Goldberg AL. Nrdp1-mediated degradation of the gigantic IAP, BRUCE, is a novel pathway for triggering apoptosis. The EMBO journal. 2004;23(4):800-10. doi:10.1038/sj.emboj.7600075. (Pubitemid 38418747)
18. Pohl C, Jentsch S. Final stages of cytokinesis and midbody ring formation are controlled by BRUCE. Cell. 2008;132(5):832-45. doi:10.1016/j.cell.2008.01. 012. (Pubitemid 351312799)
19. Chu L, Gu J, Sun L, Qian Q, Qian C, Liu X. Oncolytic adenovirus-mediated shRNA against Apollon inhibits tumor cell growth and enhances antitumor effect of 5-fluorouracil. Gene therapy. 2008;15(7):484-94. doi:10.1038/gt.2008.6. (Pubitemid 351405088)
20. Hao Y, Sekine K, Kawabata A, Nakamura H, Ishioka T, Ohata H, et al. Apollon ubiquitinates SMAC and caspase-9, and has an essential cytoprotection function. Nature cell biology. 2004;6(9):849-60. doi:10.1038/ncb1159. (Pubitemid 39207250)
21. Dong X, Lin D, Low C, Vucic EA, English JC, Yee J, et al. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2013;8(2):161-70. doi:10.1097/JTO.0b013e31827d5237.
22. Chen Y, Fu D, Xi J, Ji Z, Liu T, Ma Y, et al. Expression and clinical significance of UCH37 in human esophageal squamous cell carcinoma. Digestive diseases and sciences. 2012;57(9):2310-7. doi:10.1007/s10620-012-2181-9.